{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:17:16Z","timestamp":1794435436724,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatocellular carcinoma (HCC) is one of the most severe malignancies with increasing incidence and limited treatment options. Typically, HCC develops during a multistep process involving chronic liver inflammation and liver fibrosis. The latter is characterized by the accumulation of extracellular matrix produced by Hepatic Stellate Cells (HSCs). This process involves cell cycle re-entry and proliferation of normally quiescent HSCs in an ordered sequence that is highly regulated by cyclins and associated cyclin-dependent kinases (CDKs) such as the Cyclin E1 (CCNE1)\/CDK2 kinase complex. In the present study, we examined the role of Cyclin E1 (<jats:italic>Ccne1<\/jats:italic>) and <jats:italic>Cdk2<\/jats:italic> genes in HSCs for liver fibrogenesis and hepatocarcinogenesis. To this end, we generated conditional knockout mice lacking <jats:italic>Ccne1<\/jats:italic> or <jats:italic>Cdk2<\/jats:italic> specifically in HSCs (<jats:italic>Ccne1<\/jats:italic><jats:sup>\u2206HSC<\/jats:sup> or <jats:italic>Cdk2<\/jats:italic><jats:sup>\u2206HSC<\/jats:sup>). <jats:italic>Ccne1<\/jats:italic><jats:sup>\u2206HSC<\/jats:sup> mice showed significantly reduced liver fibrosis formation and attenuated HSC activation in the carbon tetrachloride (CCl<jats:sub>4<\/jats:sub>) model. In a combined model of fibrosis-driven hepatocarcinogenesis, <jats:italic>Ccne1<\/jats:italic><jats:sup>\u2206HSC<\/jats:sup> mice revealed decreased HSC activation even after long-term observation and substantially reduced tumor load in the liver when compared to wild-type controls. Importantly, the deletion of <jats:italic>Cdk2<\/jats:italic> in HSCs also resulted in attenuated liver fibrosis after chronic CCl<jats:sub>4<\/jats:sub> treatment. Single-cell RNA sequencing revealed that only a small fraction of HSCs expressed <jats:italic>Ccne1<\/jats:italic>\/<jats:italic>Cdk2<\/jats:italic> at a distinct time point after CCl<jats:sub>4<\/jats:sub> treatment. In summary, we provide evidence that <jats:italic>Ccne1<\/jats:italic> expression in a small population of HSCs is sufficient to trigger extensive liver fibrosis and hepatocarcinogenesis in a <jats:italic>Cdk2<\/jats:italic>-dependent manner. Thus, HSC-specific targeting of <jats:italic>Ccne1<\/jats:italic> or <jats:italic>Cdk2<\/jats:italic> in patients with liver fibrosis and high risk for HCC development could be therapeutically beneficial.<\/jats:p>","DOI":"10.1038\/s41419-023-06077-4","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T05:01:56Z","timestamp":1692853316000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Expression of Cyclin E1 in hepatic stellate cells is critical for the induction and progression of liver fibrosis and hepatocellular carcinoma in mice"],"prefix":"10.1038","volume":"14","author":[{"given":"Julia","family":"Otto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9793-5862","authenticated-orcid":false,"given":"Anna","family":"Verwaayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4360-5785","authenticated-orcid":false,"given":"Christian","family":"Penners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Hundertmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Kallen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Paffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5594-3055","authenticated-orcid":false,"given":"Tobias","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilmar","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3888-0931","authenticated-orcid":false,"given":"Ralf","family":"Weiskirchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia A.","family":"Nevzorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1516-9610","authenticated-orcid":false,"given":"Matthias","family":"Bartneck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2762-8247","authenticated-orcid":false,"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Sonntag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4681-7887","authenticated-orcid":false,"given":"Christian","family":"Liedtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"6077_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Prim. 2021;7:6.","journal-title":"Nat Rev Dis Prim"},{"key":"6077_CR2","first-page":"344","volume":"3","author":"R Weiskirchen","year":"2014","unstructured":"Weiskirchen R, Tacke F. Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. Hepatobiliary Surg Nutr. 2014;3:344\u201363.","journal-title":"Hepatobiliary Surg Nutr"},{"key":"6077_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jhep.2015.01.036","volume":"63","author":"P Kocabayoglu","year":"2015","unstructured":"Kocabayoglu P, Lade A, Lee YA, Dragomir AC, Sun X, Fiel MI, et al. beta-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis. J Hepatol. 2015;63:141\u20137.","journal-title":"J Hepatol"},{"key":"6077_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18:151\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"6077_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-1-4615-1809-9_10","volume":"1","author":"K Sauer","year":"1995","unstructured":"Sauer K, Lehner CF. The role of cyclin E in the regulation of entry into S phase. Prog Cell Cycle Res. 1995;1:125\u201339.","journal-title":"Prog Cell Cycle Res"},{"key":"6077_CR6","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/hep.25736","volume":"56","author":"YA Nevzorova","year":"2012","unstructured":"Nevzorova YA, Bangen JM, Hu W, Haas U, Weiskirchen R, Gassler N, et al. Cyclin E1 controls proliferation of hepatic stellate cells and is essential for liver fibrogenesis in mice. Hepatology. 2012;56:1140\u20139.","journal-title":"Hepatology"},{"key":"6077_CR7","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/hep.29275","volume":"66","author":"JM Bangen","year":"2017","unstructured":"Bangen JM, Hammerich L, Sonntag R, Baues M, Haas U, Lambertz D, et al. Targeting CCl4 -induced liver fibrosis by RNA interference-mediated inhibition of cyclin E1 in mice. Hepatology. 2017;66:1242\u201357.","journal-title":"Hepatology"},{"key":"6077_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0023677215571192","volume":"49","author":"D Scholten","year":"2015","unstructured":"Scholten D, Trebicka J, Liedtke C, Weiskirchen R. The carbon tetrachloride model in mice. Lab Anim. 2015;49:4\u201311.","journal-title":"Lab Anim"},{"key":"6077_CR9","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","volume":"610","author":"A Filliol","year":"2022","unstructured":"Filliol A, Saito Y, Nair A, Dapito DH, Yu LX, Ravichandra A, et al. Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. Nature. 2022;610:356\u201365.","journal-title":"Nature"},{"key":"6077_CR10","doi-asserted-by":"publisher","first-page":"9282","DOI":"10.1073\/pnas.1807155115","volume":"115","author":"R Sonntag","year":"2018","unstructured":"Sonntag R, Giebeler N, Nevzorova YA, Bangen JM, Fahrenkamp D, Lambertz D, et al. Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma. Proc Natl Acad Sci USA. 2018;115:9282\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6077_CR11","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/17474124.2018.1530110","volume":"12","author":"F Tacke","year":"2018","unstructured":"Tacke F, Weiskirchen R. An update on the recent advances in antifibrotic therapy. Expert Rev Gastroenterol Hepatol. 2018;12:1143\u201352.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"6077_CR12","doi-asserted-by":"publisher","first-page":"14 30 11","DOI":"10.1002\/0471141755.ph1430s66","volume":"66","author":"T Uehara","year":"2014","unstructured":"Uehara T, Pogribny IP, Rusyn I. The DEN and CCl4-induced mouse model of fibrosis and inflammation-associated hepatocellular carcinoma. Curr Protoc Pharm. 2014;66:14 30 11\u201310.","journal-title":"Curr Protoc Pharm"},{"key":"6077_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cytogfr.2015.10.002","volume":"28","author":"E Borkham-Kamphorst","year":"2016","unstructured":"Borkham-Kamphorst E, Weiskirchen R. The PDGF system and its antagonists in liver fibrosis. Cytokine Growth Factor Rev. 2016;28:53\u201361.","journal-title":"Cytokine Growth Factor Rev"},{"key":"6077_CR14","doi-asserted-by":"publisher","first-page":"547","DOI":"10.5604\/01.3001.0012.0916","volume":"17","author":"JR Carvalho","year":"2018","unstructured":"Carvalho JR, Verdelho Machado M. New insights about albumin and liver disease. Ann Hepatol. 2018;17:547\u201360.","journal-title":"Ann Hepatol"},{"key":"6077_CR15","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.3748\/wjg.v11.i32.5015","volume":"11","author":"D Gorog","year":"2005","unstructured":"Gorog D, Regoly-Merei J, Paku S, Kopper L, Nagy P. Alpha-fetoprotein expression is a potential prognostic marker in hepatocellular carcinoma. World J Gastroenterol. 2005;11:5015\u20138.","journal-title":"World J Gastroenterol"},{"key":"6077_CR16","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/ijc.22476","volume":"120","author":"S Yin","year":"2007","unstructured":"Yin S, Li J, Hu C, Chen X, Yao M, Yan M, et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer. 2007;120:1444\u201350.","journal-title":"Int J Cancer"},{"key":"6077_CR17","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","volume":"147","author":"F Marra","year":"2014","unstructured":"Marra F, Tacke F. Roles for chemokines in liver disease. Gastroenterology. 2014;147:577\u201394 e571.","journal-title":"Gastroenterology"},{"key":"6077_CR18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jcmgh.2018.10.007","volume":"7","author":"M Bartneck","year":"2019","unstructured":"Bartneck M, Schrammen PL, Mockel D, Govaere O, Liepelt A, Krenkel O, et al. The CCR2(+) macrophage subset promotes pathogenic angiogenesis for tumor vascularization in fibrotic livers. Cell Mol Gastroenterol Hepatol. 2019;7:371\u201390.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"6077_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/gutjnl-2015-310514","volume":"66","author":"X Li","year":"2017","unstructured":"Li X, Yao W, Yuan Y, Chen P, Li B, Li J, et al. Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut. 2017;66:157\u201367.","journal-title":"Gut"},{"key":"6077_CR20","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.3390\/cancers13225680","volume":"13","author":"R Sonntag","year":"2021","unstructured":"Sonntag R, Penners C, Kohlhepp M, Haas U, Lambertz D, Kroh A, et al. Cyclin E1 in murine and human liver cancer: a promising target for therapeutic intervention during tumour progression. Cancers (Basel). 2021;13:5680.","journal-title":"Cancers (Basel)"},{"key":"6077_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/cells8050503","volume":"8","author":"O Krenkel","year":"2019","unstructured":"Krenkel O, Hundertmark J, Ritz TP, Weiskirchen R, Tacke F. Single cell RNA sequencing identifies subsets of hepatic stellate cells and myofibroblasts in liver fibrosis. Cells. 2019;8:503.","journal-title":"Cells"},{"key":"6077_CR22","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1091\/mbc.e13-05-0264","volume":"24","author":"GD Grant","year":"2013","unstructured":"Grant GD, Brooks L 3rd, Zhang X, Mahoney JM, Martyanov V, Wood TA, et al. Identification of cell cycle-regulated genes periodically expressed in U2OS cells and their regulation by FOXM1 and E2F transcription factors. Mol Biol Cell. 2013;24:3634\u201350.","journal-title":"Mol Biol Cell"},{"key":"6077_CR23","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1091\/mbc.02-02-0030","volume":"13","author":"ML Whitfield","year":"2002","unstructured":"Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA, Alexander KE, et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell. 2002;13:1977\u20132000.","journal-title":"Mol Biol Cell"},{"key":"6077_CR24","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3389\/fcell.2020.00709","volume":"8","author":"AE Barry","year":"2020","unstructured":"Barry AE, Baldeosingh R, Lamm R, Patel K, Zhang K, Dominguez DA, et al. Hepatic stellate cells and hepatocarcinogenesis. Front Cell Dev Biol. 2020;8:709.","journal-title":"Front Cell Dev Biol"},{"key":"6077_CR25","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.tcb.2021.05.001","volume":"31","author":"C Chu","year":"2021","unstructured":"Chu C, Geng Y, Zhou Y, Sicinski P. Cyclin E in normal physiology and disease states. Trends Cell Biol. 2021;31:732\u201346.","journal-title":"Trends Cell Biol"},{"key":"6077_CR26","first-page":"2913","volume":"44","author":"J Rotstein","year":"1984","unstructured":"Rotstein J, Macdonald PD, Rabes HM, Farber E. Cell cycle kinetics of rat hepatocytes in early putative preneoplastic lesions in hepatocarcinogenesis. Cancer Res. 1984;44:2913\u20137.","journal-title":"Cancer Res"},{"key":"6077_CR27","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1242\/dev.091744","volume":"140","author":"S Lim","year":"2013","unstructured":"Lim S, Kaldis P. Cdks, cyclins and CKIs: roles beyond cell cycle regulation. Development. 2013;140:3079\u201393.","journal-title":"Development"},{"key":"6077_CR28","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/emboj\/16.2.332","volume":"16","author":"E Hara","year":"1997","unstructured":"Hara E, Hall M, Peters G. Cdk2-dependent phosphorylation of Id2 modulates activity of E2A-related transcription factors. EMBO J. 1997;16:332\u201342.","journal-title":"EMBO J"},{"key":"6077_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1073\/pnas.0900121106","volume":"107","author":"P Hydbring","year":"2010","unstructured":"Hydbring P, Bahram F, Su Y, Tronnersjo S, Hogstrand K, von der Lehr N, et al. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation. Proc Natl Acad Sci USA. 2010;107:58\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6077_CR30","doi-asserted-by":"publisher","first-page":"36966","DOI":"10.1074\/jbc.M305178200","volume":"278","author":"J Yun","year":"2003","unstructured":"Yun J, Chae HD, Choi TS, Kim EH, Bang YJ, Chung J, et al. Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway. J Biol Chem. 2003;278:36966\u201372.","journal-title":"J Biol Chem"},{"key":"6077_CR31","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1073\/pnas.0409722102","volume":"102","author":"JS Campbell","year":"2005","unstructured":"Campbell JS, Hughes SD, Gilbertson DG, Palmer TE, Holdren MS, Haran AC, et al. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci USA. 2005;102:3389\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6077_CR32","doi-asserted-by":"publisher","first-page":"627927","DOI":"10.3389\/fmed.2021.627927","volume":"8","author":"S Xi","year":"2021","unstructured":"Xi S, Zheng X, Li X, Jiang Y, Wu Y, Gong J, et al. Activated hepatic stellate cells induce infiltration and formation of CD163(+) macrophages via CCL2\/CCR2 pathway. Front Med. 2021;8:627927.","journal-title":"Front Med"},{"key":"6077_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1126\/science.1140485","volume":"317","author":"WE Naugler","year":"2007","unstructured":"Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317:121\u20134.","journal-title":"Science"},{"key":"6077_CR34","doi-asserted-by":"publisher","first-page":"5079","DOI":"10.3390\/ijms20205079","volume":"20","author":"CC Hsieh","year":"2019","unstructured":"Hsieh CC, Hung CH, Chiang M, Tsai YC, He JT. Hepatic stellate cells enhance liver cancer progression by inducing myeloid-derived suppressor cells through interleukin-6 signaling. Int J Mol Sci. 2019;20:5079.","journal-title":"Int J Mol Sci"},{"key":"6077_CR35","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.devcel.2011.08.009","volume":"21","author":"J Odajima","year":"2011","unstructured":"Odajima J, Wills ZP, Ndassa YM, Terunuma M, Kretschmannova K, Deeb TZ, et al. Cyclin E constrains Cdk5 activity to regulate synaptic plasticity and memory formation. Dev Cell. 2011;21:655\u201368.","journal-title":"Dev Cell"},{"key":"6077_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng1232","volume":"35","author":"S Ortega","year":"2003","unstructured":"Ortega S, Prieto I, Odajima J, Martin A, Dubus P, Sotillo R, et al. Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat Genet. 2003;35:25\u201331.","journal-title":"Nat Genet"},{"key":"6077_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3823","volume":"4","author":"I Mederacke","year":"2013","unstructured":"Mederacke I, Hsu CC, Troeger JS, Huebener P, Mu X, Dapito DH, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun. 2013;4:2823.","journal-title":"Nat Commun"},{"key":"6077_CR38","doi-asserted-by":"publisher","unstructured":"Lin C, Mostafa A, Jans A, Wolters JC, Mohamed MR, Van der Vorst EPC, et al. Targeting ligand independent tropism of siRNA-LNP by small molecules for directed therapy of liver or myeloid immune cells. Adv Healthc Mater. 2023: e2202670. https:\/\/doi.org\/10.1002\/adhm.202202670.","DOI":"10.1002\/adhm.202202670"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06077-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06077-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06077-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T05:01:59Z","timestamp":1692853319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06077-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["6077"],"URL":"https:\/\/doi.org\/10.1038\/s41419-023-06077-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"assertion":[{"value":"18 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were carried out according to German legal requirements and approved by the authority for environment conservation and consumer protection of the state of North Rhine-Westphalia (LANUV).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"549"}}